Prejsť na obsah Prejsť na pätičku
Log In

Industrial Property Office of the Slovak Republic - WebRegisters

Prejsť na hlavičku Prejsť na pätičku
SEARCH SIMILAR







ADD TO FAVORITES   |   PRINT   |   EXPORT TO PDF   |   SEND TO E-MAIL


ERROR REPORTING   |   PASS TO MEF
EP 3725778
(11)  Patent Number   
(96)  European Application Number  20177837.0 
(96)  European Application Date  11.09.2013 
(97)  European Patent Number  3725778 
(24)  Date from Which European Patent Has Effect  18.08.2021 
(31)  Priority Number  201261699351 P 
(32)  Priority Date  11.09.2012 
(33)  Country or Authority of Priority  US 
(97)  European Application Publication Date  21.10.2020 
(45)  European Patent Translation Publication Date   
(51)  International Patent Classification  C07D 233/86  A61K 31/4164  A61P 35/00  A61K 31/4166  A61K 9/16  A61P 13/08  A61P 15/00  A61P 15/08  A61P 15/14  A61P 43/00   
(62)  Earlier Application Number from Which the Present App. has been Divided up  13766437.1 
(86)  International Application Number   
(87)  International Publication Number   
(71/73)  Applicant(s) or Proprietor(s)  Medivation Prostate Therapeutics LLC; 235 East 42nd Street, New York, NY 10017; US;
Astellas Pharma Inc.; 2-5-1, Nihonbashi-Honcho Chuo-ku, Tokyo 103-8411; JP 
(72)  Inventor(s)  LORENZ, Douglas Alan; c/o Bend Research 64550 Research Road, Bend, OR 97701; US;
KONAGURTHU, Sanjay; c/o Bend Research 64550 Research Road, Bend, OR 97701; US;
WALD, Randy J.; c/o Bend Research 64550 Research Road, Bend, OR 97701; US;
EVERETT, Jason A.; c/o Bend Research 64550 Research Road, Bend, OR 97701; US;
MATZ, Sheila; c/o Medivation Prostate Therapeutics LLC 525 Market Street 36th Floor, San Francisco, CA 94105; US;
TAKAISHI, Yuuki; c/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411; JP;
SAKAI, Toshiro; c/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411; JP;
IRIE, Ryousuke; c/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411; JP;
OBA, Shinsuke; c/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411; JP;
TOYOTA, Hiroyasu; c/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411; JP;
NISHIMURA, Koji; c/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411; JP;
KANBAYASHI, Atsushi; c/o Astrellas Pharma Inc. 3-11 Nihonbashi-Honcho 2-chome, Chuo-Ku, Tokyo 103-8411; JP 
(74)  Attorney(s)  HÖRMANN & PARTNERS s.r.o.; Royova 19, 831 01 Bratislava - mestská časť Nové Mesto; SK 
(54)  Title  Formulácia enzalutamidu 
   Procedural Status  udelený patent 
   Legal Status   
   Licence Offer  No 
   Lien on Patent  No 
   Number of Related Application  13766437.1 
   Modified Wordings and Corrected Translations, Corrections   
   Published Patent   
   Published Translation of Claims   
   Revocation of Patent   
   Patent in Force minimum until   
   Patent in Force maximum until   
   Reason for Patent Expiration/Termination of Proceedings   
EP 3725778
S/N Fee Title Date Year Fee
1 56 udržiavací poplatok za európsky patent za 9. rok 14.09.2021 9 165,50 EUR

Disclaimer:

Paid-in Administrative Fee within Proceeding on Applications are stated in Protocol

EP 3725778
S/N Item Name Date Type Document
1 Preklad európskeho patentového spisu do slovenského jazyka 13.09.2021 Type Delivered
1a Plná moc 13.09.2021 Type Delivered
1b Sprievodný list 13.09.2021 Type Delivered
1c Opis 13.09.2021 Type Delivered
2 Poplatok za zverejnenie a sprístupnenie prekladu/opraveného prekladu/prekladu zmeneného znenia EP 20.09.2021 Type Payment
3 formálne nedostatky podania prekladu EP 26.10.2021 Type Sent document
EP 3725778
S/N Item Name Valid from New Subject Previous Subject
Prejsť na obsah Prejsť na hlavičku